Inventor · disambiguated record
Joseph Swistok
Also filed as: SWISTOK JOSEPH
7 granted patents·6 pending applications·56 citations·filing 2001–2011
82Inventor score
Top patents by PatentIndex Score
13 records- 0189US6600015B2Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activityHOFFMANN LA ROCHE·Filed 2001·Granted Jul 29, 2003·31 cites·117 claims
- 0281US7410949B2Neuropeptide-2 receptor (Y-2R) agonists and uses thereofHOFFMANN LA ROCHE·Filed 2006·Granted Aug 12, 2008·8 cites·17 claims
- 0377US7642244B2Neuropeptide-2 receptor (Y-2R) agonists and uses thereofHOFFMANN LA ROCHE·Filed 2006·Granted Jan 5, 2010·4 cites·18 claims
- 0477US7045591B2Selective cyclic peptides with melanocortin-4 receptor (MC4-R) agonist activityHOFFMANN LA ROCHE·Filed 2001·Granted May 16, 2006·12 cites·76 claims
- 0564US2008177036A1Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist ActivityCHEN LI·Filed 2008·Application pending·0 cites
- 0661US9023986B2Glucose-dependent insulinotropic peptide analogsDANHO WALEED·Filed 2011·Granted May 5, 2015·1 cites·41 claims
- 0761US2003229200A1Selective linear peptides with melanocor tin-4 receptor (MC4-R) agonist activityFiled 2003·Application pending·0 cites
- 0857US2005239711A1Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activityCHEN LI·Filed 2005·Application pending·0 cites
- 0955US8268784B2Neuropeptide-2 receptor (Y-2R) agonists and uses thereofCONDE-KNAPE KARIN·Filed 2009·Granted Sep 18, 2012·0 cites·3 claims
- 1047US8299023B2Neuropeptide-2 receptor (Y-2R) agonistsDANHO WALEED·Filed 2009·Granted Oct 30, 2012·0 cites·5 claims
- 1147US2010179093A1Neoropeptide-2-Receptor (Y-2R) AgonistsDANHO WALEED·Filed 2009·Application pending·0 cites
- 1244US2009264620A1N-Methylation of amino acidsMOSS JASON A·Filed 2009·Application pending·0 cites
- 1328US2011172147A1Neuropeptide-2 receptor (y-2r) agonistsCONDE-KNAPE KARIN·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →